Form 4 for LEXX Lexaria Bioscience Corp.
Accepted 2025-01-10 00:00:00 ET · period of report 2025-01-07 · accession 0001348362-25-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-10 | 2025-01-07 | LEXX | BUNKA CHRISTOPHER | Dir | A - Grant | $0.00 | +100.0K | 373.5K | +37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Restricted Stock Award | 2025-01-07 | A | A | 100,000 | $0.00 | 373,543 | D | — | — | (F2) The closing price on the Issuer's shares on the date of grant was $2.24. (F1) Beneficial ownership reflects the aggregate securities held directly. |